Unknown

Dataset Information

0

Genome-wide RNAi screening identifies TMIGD3 isoform1 as a suppressor of NF-?B and osteosarcoma progression.

ABSTRACT: The ability of cancer cells to survive and grow in anchorage- and serum-independent conditions is well correlated with their aggressiveness. Here, using a human whole-genome shRNA library, we identify TMIGD3 isoform1 (i1) as a factor that suppresses this ability in osteosarcoma (OS) cells, mainly by inhibiting NF-?B activity. Knockdown of TMIGD3 increases proliferation, tumour formation and metastasis of OS cells. Overexpression of TMIGD3 isoform1 (i1), but not isoform3 (i3) which shares a common C-terminal region, suppresses these malignant properties. Adenosine A3 receptor (A3AR) having an identical N-terminal region shows similar biological profiles to TMIGD3 i1. Protein expression of TMIGD3 and A3AR is lower in human OS tissues than normal tissues. Mechanistically, TMIGD3 i1 and A3AR commonly inhibit the PKA-Akt-NF-?B axis. However, TMIGD3 i1 only partially rescues phenotypes induced by A3AR knockdown, suggesting the presence of distinct pathways. Our findings reveal an unappreciated role for TMIGD3 i1 as a suppressor of NF-?B activity and OS progression.

SUBMITTER: Iyer SV 

PROVIDER: S-EPMC5133659 | biostudies-literature | 2016 Nov

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Genome-wide RNAi screening identifies TMIGD3 isoform1 as a suppressor of NF-κB and osteosarcoma progression.

Iyer Swathi V SV   Ranjan Atul A   Elias Harold K HK   Parrales Alejandro A   Sasaki Hiromi H   Roy Badal C BC   Umar Shahid S   Tawfik Ossama W OW   Iwakuma Tomoo T  

Nature communications 20161125

The ability of cancer cells to survive and grow in anchorage- and serum-independent conditions is well correlated with their aggressiveness. Here, using a human whole-genome shRNA library, we identify TMIGD3 isoform1 (i1) as a factor that suppresses this ability in osteosarcoma (OS) cells, mainly by inhibiting NF-κB activity. Knockdown of TMIGD3 increases proliferation, tumour formation and metastasis of OS cells. Overexpression of TMIGD3 isoform1 (i1), but not isoform3 (i3) which shares a commo  ...[more]

Similar Datasets

Unknown In vivo genome-wide CRISPR screening identifies ZNF24 as a negative NF-κB modulator in lung cancer.
| S-EPMC9717477 | biostudies-literature
Unknown Genome-wide RNAi screening identifies genes inhibiting the migration of glioblastoma cells.
| S-EPMC3625150 | biostudies-literature
Unknown Genome-wide in vivo RNAi screen identifies ITIH5 as a metastasis suppressor in pancreatic cancer.
| S-EPMC5450640 | biostudies-literature
Unknown Genome-wide RNAi screening identifies host restriction factors critical for in vivo AAV transduction.
| S-EPMC4568673 | biostudies-literature
Unknown Genome-wide RNAi screening identifies protein damage as a regulator of osmoprotective gene expression.
| S-EPMC1567714 | biostudies-literature
Unknown Genome-wide CRISPR screen identifies noncanonical NF-κB signaling as a regulator of density-dependent proliferation.
| S-EPMC7685705 | biostudies-literature
Unknown Genome-Wide RNAi Screen Identifies Regulators of Cardiomyocyte Necrosis.
| S-EPMC7088983 | biostudies-literature
Transcriptomics RNAi Screening Identifies that TEX10 Promotes the Proliferation of Colorectal Cancer Cells by Increasing NF-κB Activation
2020-10-05 | GSE147334 | GEO
Unknown Genome-wide screening in pluripotent cells identifies Mtf1 as a suppressor of mutant huntingtin toxicity.
| S-EPMC10322923 | biostudies-literature
Unknown Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels.
| S-EPMC8639591 | biostudies-literature